Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label Exploratory Phase II Study of the Safety and Immunogenicity of Repeated "rhC1INH" Administration of 50 U/Kg in Patients With Hereditary C1 Inhibitor Deficiency ("HAE")

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00851409
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:53.395666+00:00
Published At
2013-01-31T00:00:00+00:00
Record Updated At
2018-06-26
Results Posted At
2013-01-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Genetic Disorders", "Hereditary Angioedema"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-06-26"
protocolSection.identificationModule.nctId
"NCT00851409"
protocolSection.identificationModule.officialTitle
"An Open-label Exploratory Phase II Study of the Safety and Immunogenicity of Repeated \"rhC1INH\" Administration of 50 U/Kg in Patients With Hereditary C1 Inhibitor Deficiency (\"HAE\")"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-01-31"

Study condition terms

  • Genetic Disorders (protocolSection.conditionsModule.conditions)
  • Hereditary Angioedema (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.